GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

Начало・Списък с акции・BioArctic AB

B
BioArctic AB

Затворен

284.6 -2.47

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

284.2

Максимум

285.2

Ключови измерители
By Trading Economics
Приходи	-896M 179M
Продажби	-897M 392M
P/E Средно за сектора	23.701 35.69
EPS	1.09
Марж на печалбата	45.668
Служители	119
EBITDA	-893M 188M

Пазарни показатели
By TradingEconomics
Пазарна капитализация	4.5B 25B
Предишно отваряне	287.07
Предишно затваряне	284.6

BioArctic AB Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

26.09.2025 г., 18:25 ч. UTC

Значими двигатели на пазара

Mirion Technologies Stock Rises on Expanded Notes, Shares Offerings

27.09.2025 г., 07:00 ч. UTC

Печалби

This Water Stock Is Dehydrated. What Could Bring It Back. -- Barrons.com

27.09.2025 г., 04:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

26.09.2025 г., 21:56 ч. UTC

Придобивния, сливания и поглъщания

Staar Surgical, Insight Enterprises, and More Stocks See Action From Activist Investors -- Barrons.com

26.09.2025 г., 20:54 ч. UTC

Печалби

U.S. TikTok for $14 Billion? Making Sense of the Bargain-Basement Price. -- Barrons.com

26.09.2025 г., 20:50 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

26.09.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

26.09.2025 г., 20:27 ч. UTC

Придобивния, сливания и поглъщания

Electronic Arts Stock Pops on Report Videogame Maker Is Close to Going Private -- Barrons.com

26.09.2025 г., 20:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

26.09.2025 г., 19:54 ч. UTC

Пазарно говорене

Canada's Can't-Build Reputation Is Somewhat Earned -- Market Talk

26.09.2025 г., 19:53 ч. UTC

Придобивния, сливания и поглъщания

Electronic Arts Stock Pops on Report Videogame Maker Is Close to Going Private -- Barrons.com

26.09.2025 г., 19:40 ч. UTC

Печалби

The U.S. TikTok Is Apparently Fetching a Bargain-Basement Price. A Few Reasons Why. -- Barrons.com

26.09.2025 г., 19:24 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Mixed As October Expires -- Market Talk

26.09.2025 г., 19:17 ч. UTC

Пазарно говорене

Oil Posts Weekly Gains on Russia-Ukraine Tensions -- Market Talk

26.09.2025 г., 19:15 ч. UTC

Пазарно говорене

AI Deployment Beginning to Weigh on Job Creation, Former Central Banker Says -- Market Talk

26.09.2025 г., 19:03 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

26.09.2025 г., 19:03 ч. UTC

Пазарно говорене

Gold Fuels Stellar Performance in Toronto Stock Market -- Market Talk

26.09.2025 г., 18:50 ч. UTC

Пазарно говорене

Печалби

Costco's Executive Membership Gains Seen as Offsetting Slower Renewal Rates -- Market Talk

26.09.2025 г., 18:36 ч. UTC

Пазарно говорене

Silver Closes Out Week With Strong Surge -- Market Talk

26.09.2025 г., 18:02 ч. UTC

Придобивния, сливания и поглъщания

ING: Continue Working Towards Completing Transaction, Exit From Russian Market >ING

26.09.2025 г., 18:02 ч. UTC

Придобивния, сливания и поглъщания

ING: Global Development Hasn't Received All Necessary Approvals >ING

26.09.2025 г., 18:02 ч. UTC

Придобивния, сливания и поглъщания

ING: No Realistic Prospect of Completing Sale of ING Bank (Eurasia) to Global Development in 3Q

26.09.2025 г., 17:54 ч. UTC

Пазарно говорене

U.S. Oil Rig Count Rises For Fifth Straight Week -- Market Talk

26.09.2025 г., 16:56 ч. UTC

Пазарно говорене

Печалби

Costco Increasingly Challenged to Meet Lofty Expectations -- Market Talk

26.09.2025 г., 16:41 ч. UTC

Пазарно говорене

Печалби

Costco's Valuation Seen as Too High Amid Slow Down -- Market Talk

26.09.2025 г., 16:26 ч. UTC

Печалби

Correction to Sherwin-Williams Extends Losses. What's Ailing the Paint Maker. -- Barrons.com

26.09.2025 г., 16:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

26.09.2025 г., 16:12 ч. UTC

Пазарно говорене

Nike Stock Seen With Limited Upside -- Market Talk

26.09.2025 г., 15:59 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

26.09.2025 г., 15:59 ч. UTC

Пазарно говорене

Nike Seen Showing Progress in Turnaround -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

BioArctic AB Прогноза

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно BioArctic AB

BioArctic AB (publ) develops biological drugs for patients with disorders of the central nervous system in Sweden. The company develops Lecanemab, Lecanemab AHEAD 3-45, and Lecanemab Back-up for the treatment of Alzheimer's disease. In addition, the company develops AD-BT2802 and AD-BT2803 drug projects against Alzheimer's disease that are being combined with blood-brain barrier technology and Brain Transporter to promote uptake of antibodies into the brain. Further, it develops BAN1503, BAN2802, BAN2803, and AD2603 for the treatment of Alzheimer's disease; ND-BT3814, ND3014, andGD-BT6822 for the treatment of neurodegenerative disease; and PD1601, PD-BT2238, and PD1602 for the treatment of Parkinson's disease. It has research collaboration agreement with Eisai and AbbVie. The company was formerly known as BioArctic Neuroscience AB and changed its name to BioArctic AB (publ) in 2016. BioArctic AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.